Cargando…
Butein-instigated miR-186-5p-dependent modulation of TWIST1 affects resistance to cisplatin and bioenergetics of Malignant Pleural Mesothelioma cells
Aim: Malignant pleural mesothelioma is a chemoresistant tumor, and biphasic and sarcomatoid histologies portend the worst prognosis for malignant pleural mesothelioma (MPM) patients. We obtained the microRNA expression profile of three biphasic-sarcomatoid MPM cell lines to identify commonly express...
Autores principales: | Cioce, Mario, Rutigliano, Daniela, Puglielli, Annamaria, Fazio, Vito Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511809/ https://www.ncbi.nlm.nih.gov/pubmed/36176750 http://dx.doi.org/10.20517/cdr.2022.56 |
Ejemplares similares
-
Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma
por: Goudar, Ranjit K
Publicado: (2008) -
Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma
por: Borchert, Sabrina, et al.
Publicado: (2020) -
Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma
por: Cioce, Mario, et al.
Publicado: (2021) -
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma
por: van Haarst, J M W, et al.
Publicado: (2002) -
Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)